SLS vs. SIGA, ZVRA, GLUE, TRML, KMDA, RGNX, PHAT, AURA, PGEN, and RVNC
Should you be buying SELLAS Life Sciences Group stock or one of its competitors? The main competitors of SELLAS Life Sciences Group include SIGA Technologies (SIGA), Zevra Therapeutics (ZVRA), Monte Rosa Therapeutics (GLUE), Tourmaline Bio (TRML), Kamada (KMDA), REGENXBIO (RGNX), Phathom Pharmaceuticals (PHAT), Aura Biosciences (AURA), Precigen (PGEN), and Revance Therapeutics (RVNC). These companies are all part of the "pharmaceutical products" industry.
SELLAS Life Sciences Group vs.
SELLAS Life Sciences Group (NASDAQ:SLS) and SIGA Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, community ranking, earnings, analyst recommendations and dividends.
SELLAS Life Sciences Group received 5 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 55.56% of users gave SELLAS Life Sciences Group an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote.
17.4% of SELLAS Life Sciences Group shares are owned by institutional investors. Comparatively, 55.4% of SIGA Technologies shares are owned by institutional investors. 1.2% of SELLAS Life Sciences Group shares are owned by insiders. Comparatively, 1.5% of SIGA Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
SIGA Technologies has a net margin of 49.33% compared to SELLAS Life Sciences Group's net margin of 0.00%. SIGA Technologies' return on equity of 49.06% beat SELLAS Life Sciences Group's return on equity.
In the previous week, SIGA Technologies had 1 more articles in the media than SELLAS Life Sciences Group. MarketBeat recorded 3 mentions for SIGA Technologies and 2 mentions for SELLAS Life Sciences Group. SELLAS Life Sciences Group's average media sentiment score of 0.67 beat SIGA Technologies' score of 0.50 indicating that SELLAS Life Sciences Group is being referred to more favorably in the media.
SELLAS Life Sciences Group has a beta of 2.42, suggesting that its share price is 142% more volatile than the S&P 500. Comparatively, SIGA Technologies has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500.
SIGA Technologies has higher revenue and earnings than SELLAS Life Sciences Group. SELLAS Life Sciences Group is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
SIGA Technologies beats SELLAS Life Sciences Group on 10 of the 15 factors compared between the two stocks.
Get SELLAS Life Sciences Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SELLAS Life Sciences Group Competitors List
Related Companies and Tools
This page (NASDAQ:SLS) was last updated on 2/11/2025 by MarketBeat.com Staff
Free SLS Stock Alerts